Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism GPCR antagonists(G-protein coupled receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Abilita Therapeutics, Inc.Startup |
Active Organization Abilita Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Discovery | US | Abilita Therapeutics, Inc.Startup | - |
Neoplasms | Discovery | US | Abilita Therapeutics, Inc.Startup | - |